| 1 |
32892505 | Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays. | 2021 Feb |
1 |
| 2 |
33257607 | Obstructive mechanical mitral valve thrombosis and gastric adenocarcinoma: A therapeutic dilemma. | 2020 Nov |
1 |
| 3 |
30378437 | Assessment of Anticoagulation in Patients Receiving Ultrasound-Assisted Catheter-Directed Thrombolysis for Treatment of Pulmonary Embolism. | 2019 May |
1 |
| 4 |
31324409 | Thrombolysis Following Heparin Reversal With Protamine Sulfate in Acute Ischemic Stroke: Case Series and Literature Review. | 2019 Oct |
1 |
| 5 |
29988697 | Successful treatment of pulmonary embolism-induced cardiac arrest by thrombolysis and targeted temperature management during pregnancy. | 2018 Jul |
1 |
| 6 |
25618841 | Upper extremity acute compartment syndrome during tissue plasminogen activator therapy for pulmonary embolism in a morbidly obese patient. | 2015 |
1 |
| 7 |
23269380 | Preparation and characterization of anionic oligopeptide-modified tissue plasminogen activator for triggered delivery: an approach for localized thrombolysis. | 2013 Mar |
8 |
| 8 |
21930168 | Heparin-triggered release of camouflaged tissue plasminogen activator for targeted thrombolysis. | 2012 Jan 10 |
9 |
| 9 |
21487375 | Combined thrombolytic therapy for atrial thrombus in a preterm infant. | 2011 Apr |
1 |
| 10 |
18474426 | Thrombolysis for concomitant acute stroke and pulmonary embolism. | 2008 Aug |
1 |
| 11 |
17257362 | Catheter lock heparin concentration: effects on tissue plasminogen activator use in tunneled cuffed catheters. | 2007 Jan |
1 |
| 12 |
16601834 | Less pronounced enhancement of thrombin-dependent inactivation of plasminogen activator inhibitor type 1 by low molecular weight heparin compared with unfractionated heparin. | 2006 Apr |
1 |
| 13 |
15726889 | Mechanism of the stimulatory effect of native fucoidan, highly sulfated fucoidan and heparin on plasminogen activation by tissue plasminogen activator: the role of chloride. | 2004 Oct-Dec |
2 |
| 14 |
12759624 | Low-dose tissue plasminogen activator thrombolysis in children. | 2003 May |
1 |
| 15 |
11460009 | Maximal endothelial tissue plasminogen activator release is not impaired in patients with acute coronary syndromes before heparin treatment. | 2001 Jun |
2 |
| 16 |
10091426 | Recombinant human tissue plasminogen activator without heparin is effective in the treatment of hepatic veno-occlusive disease. | 1999 Feb |
1 |
| 17 |
10222132 | Functional changes in the conformation of thrombospondin-1 during complexation with fibronectin or heparin. | 1999 May 1 |
2 |
| 18 |
9636912 | Heparin-coated bypass circuits (Carmeda) suppress the release of tissue plasminogen activator during normothermic coronary artery bypass graft surgery. | 1998 Jun |
2 |
| 19 |
9787229 | Fibrinolytic therapy with low-dose recombinant tissue plasminogen activator in retinal vein occlusion. | 1998 |
1 |
| 20 |
9200390 | Selection of thrombolytic therapy for individual patients: development of a clinical model. GUSTO-I Investigators. | 1997 Jun |
1 |
| 21 |
8873656 | Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial. | 1996 Oct 15 |
1 |
| 22 |
8972021 | Heparin stimulation of the inhibition of activated protein C and other enzymes by human protein C inhibitor--influence of the molecular weightof heparin and ionic strength. | 1996 Dec |
1 |
| 23 |
7637394 | Successful treatment of an infant with veno-occlusive disease developed after allogeneic bone marrow transplantation by tissue plasminogen activator, heparin and prostaglandin E1. | 1995 Jul |
1 |
| 24 |
7888254 | Inhibition of superoxide production in human neutrophils by combinations of heparin and thrombolytic agents. | 1995 Jan |
1 |
| 25 |
10172669 | Alteplase: a pharmacoeconomic evaluation of its use in the management of myocardial infarction. | 1995 Nov |
1 |
| 26 |
7917699 | Thrombolysis of a modified Blalock-Taussig shunt with recombinant tissue plasminogen activator in a newborn infant with pulmonary atresia and ventricular septal defect. | 1994 Aug |
1 |
| 27 |
8167903 | Heparin and dibutyryl cAMP modulate gene expression in stimulated human saphenous vein smooth muscle cells. | 1993 Nov |
3 |
| 28 |
8204123 | An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. | 1993 Sep 2 |
1 |
| 29 |
8232430 | The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. | 1993 Nov 25 |
3 |
| 30 |
8360182 | Modulation of tissue plasminogen activator-catalyzed plasminogen activation by synthetic peptides derived from the amino-terminal heparin binding domain of fibronectin. | 1993 Sep 5 |
1 |
| 31 |
1579960 | Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. | 1992 May |
1 |
| 32 |
1806764 | Strategies for administration of tissue plasminogen activator. | 1991 Apr |
1 |
| 33 |
1905846 | Fibrin-dependent fibrinolytic activity during extracorporeal circulation. | 1991 Feb 15 |
1 |
| 34 |
1966669 | The effect of heparin and other glycosaminoglycans on levels of tissue plasminogen activator and plasminogen activator inhibitor in cultured human umbilical vein endothelial cells. | 1990 Jun |
1 |
| 35 |
2106684 | Fractionation of heparin by chromatography on a tissue plasminogen activator-Sepharose column. | 1990 Mar |
8 |
| 36 |
2122251 | A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators. | 1990 Nov 22 |
1 |
| 37 |
2123154 | A new manifestation and treatment alternative for heparin-induced thrombosis. | 1990 Dec |
1 |
| 38 |
2128972 | Heparin stimulates fibrinolysis in mesothelial cells by selective induction of tissue-plasminogen activator but not plasminogen activator inhibitor-1 synthesis. | 1990 Nov 30 |
4 |
| 39 |
3140769 | Intracerebral hemorrhage complicating intravenous tissue plasminogen activator treatment. | 1988 Oct |
1 |
| 40 |
2943315 | Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen. | 1986 Jul 15 |
1 |